Alnylam Authorizes $1 Billion Share Repurchase Program and Changes Commercial Leadership
Alnylam says its board authorized a $1 billion share repurchase program and the company will transition to new commercial leadership.
Story updates
10:16:12 PM UTC
SquawkNews
Board approved repurchases of up to $1 bln of common stock, with about $500 mln expected by the end
10:16:54 PM UTC
SquawkNews
ALNYLAM PHARMACEUTICALS - EXPECTS TO REPURCHASE $500 MLN BY END OF 2026, BALANCE IN 2027